CoChat

Autoantibodies against a 210kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis

Open access
ITOH, SHINICHI, ICHIDA, TAKAFUMI, YOSHIDA, TOSHIAKI, HAYAKAWA, AKIHITO, UCHIDA, MORIAKI, TASHIRO‐ITOH, TOMOKO, MATSUDA, YASUNOBU, ISHIHARA, KIYOSHI, ASAKURA, HITOSHI · 1998 · Journal of Gastroenterology and Hepatology
Cited by 118

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

It has been reported that the presence of anti‐nuclear antibody against a 210kDa glycoprotein of nuclear pore complex (anti‐gp210) is highly specific for primary biliary cirrhosis (PBC). The aim of the present study was to investigate the significance of anti‐gp210, especially as a prognostic marker. The presence of anti‐gp210 was ascertained in 113 patients with PBC and 162 controls by indirect immunofluorescence assay using HepG2 cells and immunoblotting analysis using nuclear extracts from HeLa cells. Anti‐gp210 was detected in 25 of the 113 (22.1%) patients. None of the 162 controls was positive for anti‐gp210. The appearance and titre of anti‐gp210 in the patients with PBC did not vary from the time of diagnosis and through their clinical course. Anti‐mitochondrial antibodies (AMA), including antibodies against pyruvate dehydrogenase complex, branched chain α‐ketoacid dehydrogenase complex and α‐ketoglutarate dehydrogenase complex, were not detected by enzyme‐linked immunosorbent assay in five of the 113 (4.4%) patients with PBC. However, anti‐gp210 alone was positive in one of these five patients. The difference in prognosis was statistically significant; patients with PBC positive for anti‐gp210 died from hepatic failure more frequently than those who were negative (P < 0.01), although there were no statistically significant differences in the frequency of jaundice and the histological stage at the time of diagnosis between the two groups. We suggest that the presence of anti‐gp210 is one of the independent prognostic markers able to predict, at the time of diagnosis, a poor outcome in patients with PBC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1440-1746.1998.01553.x

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 118

Metadata

Authors
ITOH, S., ICHIDA, T., YOSHIDA, T., HAYAKAWA, A., UCHIDA, M., TASHIRO‐ITOH, T., MATSUDA, Y., ISHIHARA, K., & ASAKURA, H.
Venue
Journal of Gastroenterology and Hepatology
Publisher
Wiley
Published
1998-03
Volume
13
Issue
3
Pages
257-265
ISSN
  • 0815-9319 (ISSN-L)
  • 1440-1746
OpenAlex
W2106004417
Cited by
118
References
7
FWCI
1.72
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Autoantibodies against a 210kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis. https://app.cochat.ai/papers/10.1111/j.1440-1746.1998.01553.x
The paper
ITOH, S., ICHIDA, T., YOSHIDA, T., HAYAKAWA, A., UCHIDA, M., TASHIRO‐ITOH, T., MATSUDA, Y., ISHIHARA, K., & ASAKURA, H. (1998). Autoantibodies against a 210kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/j.1440-1746.1998.01553.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.